(Circulation. 1997;96:3633-3640.)
© 1997 American Heart Association, Inc.
Articles |
Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels
Implications for the Control of the Protein C Pathway
From the Departments of Pathology (Z.L., A.M., C.T.E.) and Biochemistry and Molecular Biology (C.T.E.), University of Oklahoma Health Sciences Center; the Cardiovascular Biology Research Program (F.B.T., C.T.E.), Oklahoma Medical Research Foundation; and the Howard Hughes Medical Institute (G.F., C.T.E.), Oklahoma City, Okla.
Correspondence to Charles T. Esmon, PhD, Howard Hughes Medical Institute, Oklahoma Medical Research Foundation, 825 NE 13, Oklahoma City, OK 73104. E-mail Charles-Esmon{at}mrf.uokhsc.edu
Background The protein C anticoagulant pathway is critical to the control of hemostasis. Thrombomodulin and a newly identified receptor for protein C/activated protein C, EPCR, are both present on endothelium. EPCR augments activation of protein C by the thrombin-thrombomodulin complex.
Methods and Results To gain a better understanding of the relationship between thrombomodulin and EPCR, we compared the cellular specificity and tissue distributions of these two receptors by using immunohistochemistry. EPCR expression was detected almost exclusively on endothelium in human and baboon tissues. In most organs, EPCR was expressed relatively intensely on the endothelium of all arteries and veins, most arterioles, and some postcapillary venules. EPCR staining was usually negative on capillary endothelial cells. In contrast, thrombomodulin was detected at high concentrations in both large vessels and capillary endothelium. Both thrombomodulin and EPCR were expressed poorly on brain capillaries. The liver sinusoids were the only capillaries in which EPCR was expressed at moderate levels and thrombomodulin was low. EPCR and thrombomodulin were both expressed on the endothelium of vasa recta in the renal medulla, the lymph node subcapsular and medullary sinuses, and some capillaries within the adrenal gland. Even in these organs the majority of capillaries were EPCR negative or stained weakly.
Conclusions These studies suggest that EPCR may be important in enhancing protein C activation on large vessels. The presence of high levels of EPCR on arterial vessels may help explain why partial protein C deficiency is a weak risk factor for arterial thrombosis.
Key Words: thrombomodulin • vessels • anticoagulants • thrombin • coagulation
This article has been cited by other articles:
 |
|
 |
|
  R. C. Nayak, P. Sen, S. Ghosh, R. Gopalakrishnan, C. T. Esmon, U. R. Pendurthi, and L. V. M. Rao Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications Blood, August 27, 2009; 114(9): 1974 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Goring, Y. Huang, C. Mowat, C. Leger, T.-H. Lim, R. Zaheer, D. Mok, L. A. Tibbles, D. Zygun, and B. W. Winston Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1140 - C1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Perez-Casal, C. Downey, B. Cutillas-Moreno, M. Zuzel, K. Fukudome, and C. H. Toh Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects Haematologica, March 1, 2009; 94(3): 387 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gandrille Endothelial cell protein C receptor and the risk of venous thrombosis Haematologica, June 1, 2008; 93(6): 812 - 816. [Full Text] [PDF]
|
|
|
|
|
|
B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach, and S. Gandrille Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma Blood, April 1, 2008; 111(7): 3442 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gruber, U. M. Marzec, L. Bush, E. Di Cera, J. A. Fernandez, M. A. Berny, E. I. Tucker, O. J. T. McCarty, J. H. Griffin, and S. R. Hanson Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates Blood, April 1, 2007; 109(9): 3733 - 3740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Aird Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms Circ. Res., February 2, 2007; 100(2): 158 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bretschneider, B. Uzonyi, A.-A. Weber, J. W. Fischer, R. Pape, K. Lotzer, and K. Schror Human Vascular Smooth Muscle Cells Express Functionally Active Endothelial Cell Protein C Receptor Circ. Res., February 2, 2007; 100(2): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Mollica, J. T. B. Crawley, K. Liu, J. B. Rance, P. N. Cockerill, G. A. Follows, J.-R. Landry, D. J. Wells, and D. A. Lane Role of a 5'-enhancer in the transcriptional regulation of the human endothelial cell protein C receptor gene Blood, August 15, 2006; 108(4): 1251 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, X. Zheng, J.-M. Gu, G. L. Ferrell, M. Brady, N. L. Esmon, and C. T. Esmon Extraembryonic expression of EPCR is essential for embryonic viability Blood, October 15, 2005; 106(8): 2716 - 2722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ludeman, H. Kataoka, Y. Srinivasan, N. L. Esmon, C. T. Esmon, and S. R. Coughlin PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin J. Biol. Chem., April 1, 2005; 280(13): 13122 - 13128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Sommeijer, A. Beganovic, C. G. Schalkwijk, H. Ploegmakers, C. M. van der Loos, B. E. van Aken, H. ten Cate, and A. C. van der Wal More Fibrosis and Thrombotic Complications but Similar Expression Patterns of Markers for Coagulation and Inflammation in Symptomatic Plaques from DM2 Patients J. Histochem. Cytochem., September 1, 2004; 52(9): 1141 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hurtado, R. Montes, J.-C. Gris, M. L. Bertolaccini, A. Alonso, M. A. Martinez-Gonzalez, M. A. Khamashta, K. Fukudome, D. A. Lane, and J. Hermida Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death Blood, September 1, 2004; 104(5): 1369 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. de Wouwer, D. Collen, and E. M. Conway Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1374 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Saposnik, J.-L. Reny, P. Gaussem, J. Emmerich, M. Aiach, and S. Gandrille A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis Blood, February 15, 2004; 103(4): 1311 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Levi, T. T Keller, E. van Gorp, and H. ten Cate Infection and inflammation and the coagulation system Cardiovasc Res, October 15, 2003; 60(1): 26 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bates and J. I. Weitz Emerging Anticoagulant Drugs Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1491 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esmon The Protein C Pathway Chest, September 1, 2003; 124 (2009): 26S - 32S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Slungaard, J. A. Fernandez, J. H. Griffin, N. S. Key, J. R. Long, D. J. Piegors, and S. R. Lentz Platelet factor 4 enhances generation of activated protein C in vitro and in vivo Blood, July 1, 2003; 102(1): 146 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esmon Coagulation and inflammation Innate Immunity, June 1, 2003; 9(3): 192 - 198. [Abstract] [PDF]
|
|
|
|
|
|
J. B. Rance, G. A. Follows, P. N. Cockerill, C. Bonifer, D. A. Lane, and R. E. Simmonds Regulation of the human endothelial cell protein C receptor gene promoter by multiple Sp1 binding sites Blood, June 1, 2003; 101(11): 4393 - 4401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gu, J. T. B. Crawley, G. Ferrell, F. Zhang, W. Li, N. L. Esmon, and C. T. Esmon Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality J. Biol. Chem., November 1, 2002; 277(45): 43335 - 43343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esmon New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins J. Exp. Med., September 2, 2002; 196(5): 561 - 564. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Stearns-Kurosawa, K. Swindle, A. D'Angelo, P. Della Valle, A. Fattorini, N. Caron, M. Grimaux, B. Woodhams, and S. Kurosawa Plasma levels of endothelial protein C receptor respond to anticoagulant treatment Blood, January 15, 2002; 99(2): 526 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. G. Laszik, X. J. Zhou, G. L. Ferrell, F. G. Silva, and C. T. Esmon Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary Atherosclerosis Am. J. Pathol., September 1, 2001; 159(3): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Faust, M. Levin, O. B. Harrison, R. D. Goldin, M. S. Lockhart, S. Kondaveeti, Z. Laszik, C. T. Esmon, and R. S. Heyderman Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis N. Engl. J. Med., August 9, 2001; 345(6): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. B. Taylor Jr, G. T. Peer, M. S. Lockhart, G. Ferrell, and C. T. Esmon Endothelial cell protein C receptor plays an important role in protein C activation in vivo Blood, March 15, 2001; 97(6): 1685 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kurosawa, C. T. Esmon, and D. J. Stearns-Kurosawa The Soluble Endothelial Protein C Receptor Binds to Activated Neutrophils: Involvement of Proteinase-3 and CD11b/CD18 J. Immunol., October 15, 2000; 165(8): 4697 - 4703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gu, K. Fukudome, and C. T. Esmon Characterization and Regulation of the 5'-Flanking Region of the Murine Endothelial Protein C Receptor Gene J. Biol. Chem., April 21, 2000; 275(17): 12481 - 12488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J D Pearson Normal endothelial cell function Lupus, March 1, 2000; 9(3): 183 - 188. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Lane and P. J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood, March 1, 2000; 95(5): 1517 - 1532. [Full Text] [PDF]
|
|
|
|
|
|
F. B. Taylor Jr, D. J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A. C. K. Chang, Z. Laszik, S. Kosanke, G. Peer, and C. T. Esmon The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis Blood, March 1, 2000; 95(5): 1680 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gu, Y. Katsuura, G. L. Ferrell, P. Grammas, and C. T. Esmon Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo Blood, March 1, 2000; 95(5): 1687 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Y. Liaw, P. F. Neuenschwander, M. D. Smirnov, and C. T. Esmon Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function J. Biol. Chem., February 25, 2000; 275(8): 5447 - 5452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, D. Qu, N. L. Esmon, and C. T. Esmon Metalloproteolytic Release of Endothelial Cell Protein C Receptor J. Biol. Chem., February 25, 2000; 275(8): 6038 - 6044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Simmonds and D. A. Lane Structural and Functional Implications of the Intron/Exon Organization of the Human Endothelial Cell Protein C/Activated Protein C Receptor (EPCR) Gene: Comparison With the Structure of CD1/Major Histocompatibility Complex alpha 1 and alpha 2 Domains Blood, July 15, 1999; 94(2): 632 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Lentz, J. A. Fernandez, J. H. Griffin, D. J. Piegors, R. A. Erger, M. R. Malinow, and D. D. Heistad Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C System Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1744 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, N. L. Esmon, and C. T. Esmon Reconstitution of the Human Endothelial Cell Protein C Receptor with Thrombomodulin in Phosphatidylcholine Vesicles Enhances Protein C Activation J. Biol. Chem., March 5, 1999; 274(10): 6704 - 6710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kurosawa, D.J. Stearns-Kurosawa, C. W. Carson, A. D' Angelo, P. Della Valle, and C. T. Esmon Plasma Levels of Endothelial Cell Protein C Receptor Are Elevated in Patients With Sepsis and Systemic Lupus Erythematosus: Lack of Correlation With Thrombomodulin Suggests Involvement of Different Pathological Processes Blood, January 15, 1998; 91(2): 725 - 727. [Full Text] [PDF]
|
|
|
|
|
|
S. Dayal, T. Bottiglieri, E. Arning, N. Maeda, M. R. Malinow, C. D. Sigmund, D. D. Heistad, F. M. Faraci, and S. R. Lentz Endothelial Dysfunction and Elevation of S-Adenosylhomocysteine in Cystathionine {beta}-Synthase-Deficient Mice Circ. Res., June 8, 2001; 88(11): 1203 - 1209. [Abstract] [Full Text] [PDF]
|
|